Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Accumulated Expenses (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed Accumulated Expenses for 11 consecutive years, with $106567.0 as the latest value for Q1 2026.

  • For Q1 2026, Accumulated Expenses rose 154.26% year-over-year to $106567.0; the TTM value through Feb 2026 reached $106567.0, up 154.26%, while the annual FY2025 figure was $58208.0, 74.38% up from the prior year.
  • Accumulated Expenses was $106567.0 for Q1 2026 at Cannabis Suisse, up from $90625.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $209620.0 in Q1 2022, with the low at $675.0 in Q4 2022.
  • Historically, Accumulated Expenses has averaged $56262.5 across 5 years, with a median of $37646.0 in 2024.
  • The largest annual shift saw Accumulated Expenses crashed 99.61% in 2022 before it skyrocketed 8561.04% in 2023.
  • Over 5 years, Accumulated Expenses stood at $675.0 in 2022, then skyrocketed by 8561.04% to $58462.0 in 2023, then tumbled by 55.58% to $25969.0 in 2024, then soared by 248.97% to $90625.0 in 2025, then increased by 17.59% to $106567.0 in 2026.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $106567.0 in Q1 2026, $90625.0 in Q4 2025, and $74505.0 in Q3 2025.